Indication
Meningococcal Immunisation
3 clinical trials
8 products
Clinical trial
Immunogenicity and Safety of a Single Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Children, Adolescents, and Adults 2 to 55 Years of AgeStatus: Completed, Estimated PCD: 2020-11-07
Clinical trial
Immunogenicity and Safety of a Booster Dose of an Investigational Quadrivalent Meningococcal Conjugate Vaccine in Adolescents and AdultsStatus: Completed, Estimated PCD: 2020-09-14
Clinical trial
Immunogenicity and Safety of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Versus Nimenrix® or NeisVac-C® in Healthy Toddlers 12 to 23 Months of AgeStatus: Completed, Estimated PCD: 2020-10-14
Product
MenACYW Conjugate